Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association’s annual Scientific Sessions, set for Nov. 16-18.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
